Tari Leslie (CIK 0001870270)

Latest company ownership

Role: CHIEF SCIENTIFIC OFFICER
Shares held
15,849
Last filed at
Jul 6, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 11, 2025 Mar 13, 2025 Cidara Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 46.3 -1,773 -9.82% $38.9K
Sep 11, 2024 Sep 13, 2024 Cidara Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 46.3 -909 -4.84% $10.6K
Mar 11, 2024 Mar 12, 2024 Cidara Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 46.3 -21,029 -7.48% $14.1K
Sep 11, 2023 Sep 13, 2023 Cidara Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 46.3 -18,469 -6.25% $17.5K
Aug 14, 2023 Aug 14, 2023 Cidara Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Buy 82.5 +10,000 3.50% $9.7K
Mar 13, 2023 Mar 13, 2023 Cidara Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 46.3 -7,562 -3.80% $11.6K
Jan 12, 2023 Jan 27, 2023 Cidara Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 26.3 -11,814 -5.60% $14.2K
Sep 12, 2022 Sep 13, 2022 Cidara Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 46.3 -18,159 -8.06% $12.4K
Dec 29, 2021 Jan 7, 2022 Cidara Therapeutics, Inc. Chief Scientific Officer Sell 50.0 -1,252 -0.74% $1.6K